Special Announcement - Important Clinical Information for Pandemic Response

August 6, 2021 Please join an important webinar NEXT TUESDAY focusing on how monoclonal antibodies and other therapeutics can help prevent serious illness from COVID-19. This webinar will feature Michael R. Anderson, MD, a Senior Advisor to HHS' Assistant Secretary for Preparedness and Response (ASPR). Read more about the webinar and Dr. Anderson below. The Critical Role of Monoclonal Antibodies as the COVID-19 Pandemic Continues Tuesday, August 10 4:00-5:00 p.m. ET Join the day of the session If you prefer to join by phone: 833-568-8864 When prompted, enter meeting/webinar ID: 160 055 0780 and passcode: 828587 The webinar will be recorded for those who cannot make the session.  However, we strongly encourage providers who have questions about COVID-19 treatments to attend so they can participate in the Q&A portion. About the Webinar In the continued fight against COVID-19, we have seen how important monoclonal antibodies and other therapeutics are in helping prevent serious illness. As viral variants arise and spread, it is increasingly critical that health care providers have the latest treatment information at their fingertips. Dr. Anderson will share updates on available COVID-19 therapeutics including medication efficacy, new administration routes and novel treatments in the pipeline, fee reimbursement resources, and provider and patient tools and fact sheets. Dr. Anderson and HRSA representatives will also be available for a Q&A to answer providers' questions about these important COVID-19 therapies. About the Presenter Michael R. Anderson, MD, MBA, FAAP, FCCM, FAARC, is a pediatric critical care physician, health care executive, child advocate, and a nationally renowned expert in disaster response and health policy. During the COVID-19 pandemic, he was asked to join HHS full time and is currently a Senior Advisor to HHS' ASPR in Washington, D.C. He is a key leader on the COVID-19 monoclonal antibody therapeutics team and has deployed with federal COVID-19 monoclonal antibody administration teams and focused on stakeholder engagement, product distribution, and the creation of innovative infusion centers aimed at saving lives and preserving hospital capacity. The Announcements from the Federal Office of Rural Health Policy are distributed weekly on Thursdays. To receive these updates, send an email with "Subscribe" in the subject line.  Connect with HRSA To learn more about our agency, visit www.HRSA.gov  Sign up for eNews Follow Us:        Subscriber Services: Manage Preferences / Unsubscribe  |  Help  Health Resources and Services Administration 5600 Fishers Lane Rockville, MD 20857 This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: HRSA · 5600 Fishers Lane · Rockville, MD 20857